EMG
MNOV icon

Ellington Management Group’s MediciNova MNOV Stock Holding History

Ellington Management Group’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-12,600
Closed -$129K – 704
2018
Q1 		$129K Buy
+12,600
New +$126K 0.01% 771

Other funds holding MNOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ellington Management Group's MNOV Position: Q2 2018 in Review

Ellington Management Group sold out of MediciNova (MNOV) in Q2 2018, closing a stake of 12,600 shares — an estimated $129K sold.

Ellington Management Group first reported a position in MNOV in Q1 2018 and held it in 1 quarter. The position peaked at $129K in Q1 2018. 55 funds tracked by Wall St. Rank hold MNOV as of Q2 2018.

  • Ellington Management Group reported no remaining MediciNova position as of Q2 2018 after selling out during the quarter.
  • Ellington Management Group sold 12,600 MediciNova shares in Q2 2018, an estimated $129K.
  • Ellington Management Group first reported a position in MediciNova in Q1 2018 and held it in 1 quarter.
  • Ellington Management Group's MediciNova position peaked at $129K in Q1 2018.
  • 55 funds tracked by Wall St. Rank held MediciNova as of Q2 2018.

Based on Ellington Management Group's 13F filing for Q2 2018, filed 14 Aug 2018.